G6PC1 and hepatocellular carcinoma: On one hand, high miR-494 circulating levels associated with low tissue metabolic gene (G6pc and ETFDH) expression, highlighting the potential of identifying an HCC subgroup with miR-494-related metabolic alterations that might represent a treatable vulnerability to complement actual therapies.